Clinical Trials Browser

Phase 2 × Ointments × Gastrointestinal × Clear all

NCT01593995 2014-11-04

EGF Ointment for Erlotinib Skin Lesion

Phase 2 Completed

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms